Global Mycoplasma Testing Market Report 2022 to 2030: Increasing Need for Mycoplasma Quality Control for Cell Substrates and Biopharmaceuticals Presents Opportunities
15 nov. 2022 07h58 HE
|
Research and Markets
Dublin, Nov. 15, 2022 (GLOBE NEWSWIRE) -- The "Mycoplasma Testing Market Size, Share & Trends Analysis by Product (Instruments, Kit & Reagents), by Technology (PCR, ELISA), by Application...
Blue Water Vaccines Reports Third Quarter 2022 Financial Results and Recent Business Highlights; Announces 5 Million Share Repurchase Program
10 nov. 2022 08h47 HE
|
Blue Water Vaccines Inc.
Closed private placement in August 2022, with net proceeds of approximately $8.7 millionAnnounced plans to evaluate efficacy of BWV-201 for protection against non-invasive pneumococcal pneumonia in...
The Worldwide Legionella Testing Industry is Projected to Reach $439 Million by 2027
14 sept. 2022 05h58 HE
|
Research and Markets
Dublin, Sept. 14, 2022 (GLOBE NEWSWIRE) -- The "Legionella Testing Market by Test Type (Culture, Urinary Antigen Test, DFA, PCR), Application (Water & IVD Testing (Urine, Blood)), End User...
At 6% CAGR, Pneumonia Testing Market Size to Hit USD 912.5 Million by 2029
16 août 2022 08h22 HE
|
Fortune Business Insights
Pune, India, Aug. 16, 2022 (GLOBE NEWSWIRE) -- The global pneumonia testing market size hit USD 557.1 million in 2021. The market valuation is slated to rise from USD 606.6 million in 2022 to USD...
Global Legionella Testing Market (2022 to 2027) - Industry Trends, Share, Size, Growth, Opportunity and Forecasts
17 juin 2022 08h28 HE
|
Research and Markets
Dublin, June 17, 2022 (GLOBE NEWSWIRE) -- The "Legionella Testing Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to...
Insights on the Infection Surveillance Solutions Global Market to 2027 - by Component, Deployment Type, End-user and Region
07 juin 2022 08h13 HE
|
Research and Markets
Dublin, June 07, 2022 (GLOBE NEWSWIRE) -- The "Infection Surveillance Solutions Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to...
BioAegis Therapeutics Completes $22 Million Institutional Sale of Equity in a Non-Brokered Transaction
22 mars 2022 05h00 HE
|
BioAegis Therapeutics
NORTH BRUNSWICK, N.J., March 22, 2022 (GLOBE NEWSWIRE) -- BioAegis Therapeutics, Inc., a clinical-stage, private company developing therapies for inflammatory, infectious, and degenerative diseases...
BioAegis Therapeutics Announces Appointment of Two New Corporate Board Members
17 févr. 2022 17h42 HE
|
BioAegis Therapeutics
NORTH BRUNSWICK, N.J., Feb. 17, 2022 (GLOBE NEWSWIRE) -- BioAegis Therapeutics, Inc., a clinical-stage, private company developing therapies for inflammatory, infectious, and degenerative diseases...
BioAegis’ Novel Host-directed Human Protein for Inflammatory Diseases Geared for Growth in 2022
24 janv. 2022 15h52 HE
|
BioAegis Therapeutics
NORTH BRUNSWICK, N.J., Jan. 24, 2022 (GLOBE NEWSWIRE) -- BioAegis Therapeutics Inc., a clinical-stage, private company developing therapies for infectious, inflammatory and degenerative diseases...
Global Interventional Pulmonology Market Report 2021-2025 with Regional Analysis of Bronchoscopy Examination Procedures
20 janv. 2022 05h03 HE
|
Research and Markets
Dublin, Jan. 20, 2022 (GLOBE NEWSWIRE) -- The "Global Interventional Pulmonology Market: Size, Trends & Forecast with Impact Analysis of COVID-19 (2021-2025)" report has been added to...